Pharmacological stabilization of intracranial aneurysms in mice: a feasibility study. - Wikidata - awgldk - TriplyDB

Pharmacological stabilization of intracranial aneurysms in mice: a feasibility study.

Pharmacological stabilization of intracranial aneurysms in mice: a feasibility study.

http://www.wikidata.org/entity/Q36195021

about

Aneurysmal Subarachnoid Hemorrhage and Neuroinflammation: A Comprehensive Review Successful serial imaging of the mouse cerebral arteries using conventional 3-T magnetic resonance imaging.Inflammatory mediators in vascular disease: identifying promising targets for intracranial aneurysm research Cerebral aneurysms: formation, progression, and developmental chronology Smooth Muscle Peroxisome Proliferator-Activated Receptor γ Plays a Critical Role in Formation and Rupture of Cerebral Aneurysms in Mice In Vivo Critical role of TNF-α in cerebral aneurysm formation and progression to rupture.Estrogen protects against intracranial aneurysm rupture in ovariectomized mice.Angiotensin 1-7 reduces mortality and rupture of intracranial aneurysms in mice.Roles of estrogen in the formation of intracranial aneurysms in ovariectomized female mice.Protective Role of Peroxisome Proliferator-Activated Receptor-γ in the Development of Intracranial Aneurysm Rupture Angiotensin-(1-7) protects against the development of aneurysmal subarachnoid hemorrhage in mice Preemptive Medicine for Cerebral Aneurysms Roles of hypertension in the rupture of intracranial aneurysms.Human Mesenchymal Stem Cell-Derived Microvesicles Prevent the Rupture of Intracranial Aneurysm in Part by Suppression of Mast Cell Activation via a PGE2-Dependent Mechanism.Translational research using a mouse model of intracranial aneurysm.Insights into the activity, differential expression, mutual regulation, and functions of matrix metalloproteinases and a disintegrin and metalloproteinases in hypertension and cardiac disease.Mouse models of intracranial aneurysm.Treatment of unruptured intracranial aneurysms: a review.Unruptured Cerebral Aneurysms in Elderly Patients.Bazedoxifene, a selective estrogen receptor modulator, reduces cerebral aneurysm rupture in Ovariectomized rats Concomitant coiling reduces metalloproteinase levels in flow diverter-treated aneurysms but anti-inflammatory treatment has no effect.Protective Effect of Mesenchymal Stem Cells Against the Development of Intracranial Aneurysm Rupture in Mice.Cigarette Smoke Initiates Oxidative Stress-Induced Cellular Phenotypic Modulation Leading to Cerebral Aneurysm Pathogenesis.Elastase-induced intracranial dolichoectasia model in mice.A Comparison of Pathophysiology in Humans and Rodent Models of Subarachnoid Hemorrhage.Primary Cilia Deficiency Induces Intracranial Aneurysm.AGD: Aneurysm Gene Database

P2860

Q26751399-4361FD6C-A2E5-4546-8DDF-FBDF99232264 Q27321087-82CB5CFE-C426-4636-BA04-04BC9AF72E1F Q28084855-D5D37E98-81F4-45D3-BE45-260588B7016C Q28649596-CF7DB545-CE5E-4375-8E5D-82EC397B7C89 Q30300042-6396E189-CAAA-43C0-B1F8-59D28CD124AC Q30413049-06FCD694-B3E4-4899-A225-8B706C4303CF Q33667438-A599B959-A82B-44DE-B4B4-2CB1A45E1D44 Q33895288-55C7E4E6-F4C9-4A20-8335-1F6030A26F3B Q35445299-0805D31C-B05C-4126-A73F-85E5082D6613 Q35660853-7A115ECD-CFA9-4367-A32D-DD4B952A5620 Q36267261-2B5EBBC6-862E-44CA-B168-277921FF7FC5 Q37263620-7CD77336-7889-491C-8755-96871845EB9F Q37605111-8DF40AC1-94B9-4B99-9022-693CF5CF585C Q37619229-2A6F7A72-D73F-45AF-BF01-5D389A3805CE Q37639357-3941F193-ED40-4A42-99FD-E2A3CCD46965 Q38061567-3E9D0C55-B433-4E0A-A1DD-B3582DBC4D33 Q38231586-4FB7B49E-78DF-4687-BE25-D12C4DD91F6E Q38854358-627EA324-48E9-452A-BA47-D5E1DAFF93A0 Q39253538-08EA01FA-FB5B-45ED-83D9-F0E579820835 Q42284550-BE02D9AF-3754-4817-9AB0-53477B0F3AA6 Q45029481-5FF250EF-1EEE-44A8-AD33-330D7074F6A6 Q46035036-03929F0C-62BB-4048-A21A-C631D3D3A06B Q47724846-6482A941-0192-4766-873B-6A30E07F6A2B Q48371028-722F7076-723C-4F5C-93E7-6DEA196507F8 Q55019304-5D9A370C-C90D-4765-8914-C376861DA637 Q55271876-0AAA1EFD-42FC-4B57-A57A-30737333389E Q58696270-E724E94E-FE1E-4658-B49A-C06ECD49C51C

P2860

Pharmacological stabilization of intracranial aneurysms in mice: a feasibility study.

http://www.wikidata.org/entity/Q36195021

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Pharmacological stabilization of intracranial aneurysms in mice: a feasibility study.

@ast

Pharmacological stabilization of intracranial aneurysms in mice: a feasibility study.

@en

type

label

Pharmacological stabilization of intracranial aneurysms in mice: a feasibility study.

@ast

Pharmacological stabilization of intracranial aneurysms in mice: a feasibility study.

@en

prefLabel

Pharmacological stabilization of intracranial aneurysms in mice: a feasibility study.

@ast

Pharmacological stabilization of intracranial aneurysms in mice: a feasibility study.

@en

P1433

Q36195021-3BE342F4-0B5F-429B-8B61-43488CABD5F7

P1476

Q36195021-5C3EA3DD-FE62-4798-B700-57E4D27D2C01

P2093

Q36195021-004A0D3F-6218-4745-B7F5-AF5FF752BA52

Q36195021-0855672D-7FC9-4008-8250-935034243FE5

Q36195021-165CC1D5-ED42-44CA-ABC1-191E72CD0AB2

Q36195021-2AD1E6A5-3DA5-4D39-8D1F-F4CCCE90F1D9

Q36195021-2CF4A76B-802C-47AB-95C0-B9CE827354E0

Q36195021-6E1DBD16-6C89-4BD3-A44E-A70107C449A6

Q36195021-A89E3552-7553-4063-9C16-474D3D4A1502

Q36195021-BA345071-E1C5-4A4C-B825-37615929FE8D

Q36195021-C0751B18-23F2-4D73-8563-BE56DB8820A7

Q36195021-C7304DAF-EA8A-4963-9B18-F0CC8A151249

P2860

Q36195021-0D7DD539-EA48-47A1-8867-16404A8F41B4

Q36195021-1CC7BFD3-BB06-4B22-B2AC-3E33F5B61723

Q36195021-2A9F4724-9FAF-4B8C-A185-B56D50355FCA

Q36195021-2F0B8FEB-AFF6-4328-AE23-7BAA9255CDCE

Q36195021-325BD9B4-92EF-4F0A-9641-C7BC14075F9C

Q36195021-367D4B40-E820-4E30-8B4C-2941AD4A8062

Q36195021-418E177B-8E47-43FC-B88C-9D9A35C61733

Q36195021-4704284F-C1AF-4DA9-BE75-E00DB20799D8

Q36195021-587780B1-0D56-4184-9986-09D9DAF65056

Q36195021-61228E2E-F13C-402D-94DE-90D9E6629714

P304

Q36195021-B98E8CF2-87D1-477F-8A07-30D33B5B6057

P31

Q36195021-75940669-785A-464C-BE4C-9D39CCCE7CF3

P356

Q36195021-EB4F65F3-764A-4274-B2C7-FAC636A03FE0

P407

Q36195021-82DC8F44-33F4-4A77-AD1C-6A480E96BB3D

P433

Q36195021-2A04A6C9-3286-42AB-9A5F-9D77805D3F79

P478

Q36195021-F6DAB34A-209E-4940-AF07-D99A8C743069

P577

Q36195021-43E55457-2A4A-4019-B502-4364D8784F6E

P698

Q36195021-F3EBA9CC-EF3C-471D-8D8D-B3A3E0271A92

P932

Q36195021-3110FF98-5008-44C7-9D61-118D10DFAFF6

P356

STROKEAHA.112.659821

P1433

P1476

Pharmacological stabilization of intracranial aneurysms in mice: a feasibility study.

@en

P2093

Chie Kurihara

http://www.w3.org/2001/XMLSchema#string

Elena I Liang

http://www.w3.org/2001/XMLSchema#string

Emma Palova

http://www.w3.org/2001/XMLSchema#string

Hiroshi Makino

http://www.w3.org/2001/XMLSchema#string

Keiko Kitazato

http://www.w3.org/2001/XMLSchema#string

Kosuke Wada

http://www.w3.org/2001/XMLSchema#string

Mayland Chang

http://www.w3.org/2001/XMLSchema#string

Miyuki Kanematsu

http://www.w3.org/2001/XMLSchema#string

Shahriar Mobashery

http://www.w3.org/2001/XMLSchema#string

Tomoki Hashimoto

http://www.w3.org/2001/XMLSchema#string

P2860

Targeted gene disruption of matrix metalloproteinase-9 (gelatinase B) suppresses development of experimental abdominal aortic aneurysms

Neurological and neurobehavioral assessment of experimental subarachnoid hemorrhage.

Pharmacologically induced thoracic and abdominal aortic aneurysms in mice.

Impact of hospital-related factors on outcome after treatment of cerebral aneurysms.

Critical roles of macrophages in the formation of intracranial aneurysm

Efficacy of minocycline in patients with amyotrophic lateral sclerosis: a phase III randomised trial.

Matrix metalloproteinase inhibitor development and the remodeling of drug discovery.

Effect of synthetic matrix metalloproteinase inhibitors on lipopolysaccharide-induced blood-brain barrier opening in rodents: Differences in response based on strains and solvents.

Aspirin as a promising agent for decreasing incidence of cerebral aneurysm rupture.

Minocycline for short-term neuroprotection

P304

2450-2456

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1161/STROKEAHA.112.659821

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

43

http://www.w3.org/2001/XMLSchema#string

P577

2012-07-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22798328

http://www.w3.org/2001/XMLSchema#string

P932

3429647

http://www.w3.org/2001/XMLSchema#string